<- Go Home

Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF

Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF is an exchange traded fund launched and managed by Invesco Capital Management LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across biotechnology and genome companies sectors. It invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the Dynamic Biotech & Genome Intellidex Index, by using full replication technique. Invesco Exchange-Traded Fund Trust - Invesco Biotechnology & Genome ETF was formed on June 23, 2005 and is domiciled in the United States.

Market Cap

$233.5M

Volume

7.8K

Cash and Equivalents

$5.7K

EBITDA

N/A

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$1.2M

Profit Margin

100.00%

52 Week High

$72.84

52 Week Low

$54.52

Dividend

0.06%

Price / Book Value

1.09

Price / Earnings

37.74

Price / Tangible Book Value

1.09

Enterprise Value

$233.3M

Enterprise Value / EBITDA

N/A

Operating Income

-$186.5K

Return on Equity

2.73%

Return on Assets

-0.04

Cash and Short Term Investments

$144.1K

Debt

N/A

Equity

$221.3M

Revenue

$1.2M

Unlevered FCF

N/A

Sector

Capital Markets

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches